Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Medizinische Universitaet Innsbruck
Sponsor

Medizinische Universitaet Innsbruck

Austria Innrain 52, 6020 Innsbruck, Austria

About the sponsor

Research activity includes migraine and restless leg syndrome, with interest in neurochemical and symptom-based outcomes linked to treatment response.

  • migraine
  • restless leg syndrome
  • cortical and thalamic neurochemistry
  • clinical symptom control

The sponsor’s neurology portfolio also extends to treatment-related changes in brain metabolism and movement-related sensory symptoms.

About Specializations

Medizinische Universitaet Innsbruck runs clinical trials in conditions such as Nephropathy, Hepatitis alcoholic, Anaesthesia, Restless legs syndrome, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

8 clinical trials

Nephropathy

Recruiting

A study to evaluate the efficacy and safety of obinutuzumab compared to prednisolone in adults with newly onset minimal change disease

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Obinutuzumab
  • Sponsor:Medizinische Universitaet Innsbruck

Hepatitis alcoholic

Recruiting

Study on the Effects of Alpha-1 Antitrypsin and Prednisolone in Patients with Severe Alcohol-Related Hepatitis

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Prednisolone
  • Sponsor:Medizinische Universitaet Innsbruck

Anaesthesia

Recruiting

Study on the Effects of Ropivacaine and Lidocaine in Patients Receiving Cardiac Device Implants

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Lidocaine Hydrochloride
  • Sponsor:Medizinische Universitaet Innsbruck

Restless legs syndrome

Recruiting

Study on the Effects of Ferric Derisomaltose and Dopaminergic Therapy for Patients with Restless Legs Syndrome

Registered drug
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Ferric Derisomaltose
  • Sponsor:Medizinische Universitaet Innsbruck

Plasma cell myeloma

Recruiting

Study on Daratumumab, Carfilzomib, Pomalidomide, and Dexamethasone for Patients with Multiple Myeloma and Acute Kidney Failure

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Carfilzomib
  • Sponsor:Medizinische Universitaet Innsbruck

Schizophrenia

Recruiting

Study on the Effects of Cariprazine on Cognitive Function in Schizophrenia Patients Needing Antipsychotic Treatment Adjustment

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Cariprazine
  • Sponsor:Medizinische Universitaet Innsbruck

Non-small cell lung cancer

Not recruiting

Study of Pembrolizumab and Lenvatinib for Patients with Resectable Non-Small-Cell Lung Cancer

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Lenvatinib
  • Sponsor:Medizinische Universitaet Innsbruck

Migraine

Not recruiting

Study on Migraine: Effects of Fremanezumab on Brain Chemistry in Patients with and without Aura

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years
  • Substances:Fremanezumab
  • Sponsor:Medizinische Universitaet Innsbruck

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.